JOHNSON & JOHNSON (JNJ)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for JNJ
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| JNJ | Former Global Chairman and Chief Executive Officer, Ernst & Young | 64 | [] | ["C"] | 2026 |
Biography sourced from the proxy statement filing.
Age: 64 Independent Director since 2019 Committees: Chair, Regulatory Compliance & Sustainability Member, Audit Member, Special Committee Orthopaedics Separation Career highlights Ernst & Young (retired) Global Chairman and Chief Executive Officer U.S. Government Assistant Secretary of the U.S. Treasury (George W. Bush Administration) U.S. Social Security Administration Advisory Board (Bill Clinton Administration) Other public board service JPMorganChase (since 2024) MetLife Inc. (since 2019) Saudi Aramco (since 2019) Accelerate Acquisition Corp. (2021-2022) Other affiliations & accreditations Senior Advisor to Tanium, Inc., Stone Canyon Industries Holdings Inc., and Teneo Director, National Bureau of Economic Research Director, JUST Capital Skills & qualifications Experience leading a global business and working at the highest levels of government Track record of driving transformative change in the public and private sectors during periods of unprecedented disruption Expertise in accounting, compliance and corporate governance, with a strong commitment to corporate purpose